Pharmacologic management of constipation in the critically ill patient

被引:36
|
作者
Patanwala, Asad E.
Abarca, Jacob
Huckleberry, Yvonne
Erstad, Brian L.
机构
[1] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA
[2] Univ Arizona, Coll Pharm, Ctr Hlth Outcomes & PharmacoEcon Res, Tucson, AZ 85721 USA
来源
PHARMACOTHERAPY | 2006年 / 26卷 / 07期
关键词
constipation; bowel movement; medical intensive care unit; critically ill patient; opioid; stimulant laxative; osmotic laxative;
D O I
10.1592/phco.26.7.896
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To compare the effectiveness of common laxatives in producing a bowel movement in patients admitted to a medical intensive care unit (MICU). Design. Retrospective medical record review. Setting. MICU of an academic medical center. Patients. Ninety-five patients admitted to the MICU from July 1-October 3 1, 2004. Measurements and Main Results. Fifty patients satisfied the inclusion criteria. Patient-specific data such as age, weight, sex, length of MICU stay, Acute Physiology and Chronic Health Evaluation (APACHE) 11 score, dietary intake, opioid intake, laxative intake, and bowel movements were recorded during the first 96 hours of admission. Logistic regression analysis was used to compare patients who did and did not have a bowel movement. Of the 50 patients, 25 did not have a bowel movement during the first 96 hours of MICU admission. Patients given a stimulant laxative (senna, bisacodyl) and/or an osmotic laxative (lactulose, milk of magnesia) were more likely to have a bowel movement (odds ratio [OR] 26.6, 95% confidence interval [CI] 3.2-221, p=0.002). Opioid intake, expressed as logarithmic morphine equivalents, was negatively associated with occurrence of a bowel movement (OR 0.76, 95% CI 0.59-0.97, p=0.027). Disease severity, as determined by APACHE 11 score, was also negatively associated with a bowel movement (OR 0.84, 95% CI 0.7-0.99, p=0.04). Conclusion. Critically ill patients have a high frequency of constipation, and opioid therapy is a significant risk factor. Routine administration of stimulant or osmotic laxatives should be considered for this patient population.
引用
收藏
页码:896 / 902
页数:7
相关论文
共 50 条
  • [21] THE PHARMACOLOGIC APPROACH TO THE CRITICALLY ILL PATIENT - CHERNOW,B, LAKE,CR
    TANJA, JJ
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 1984, 48 (01) : 110 - 110
  • [22] Optimal pharmacologic treatment of the critically ill patient with obstructive airways disease
    Siefkin, AD
    AMERICAN JOURNAL OF MEDICINE, 1996, 100 : S54 - S61
  • [23] Patient Blood Management for the Critically-Ill Patient
    Littlejohn, James
    Shen, Liang
    Srivastava, Ankur
    Navare, Sagar
    Barnhard, Sarah
    CURRENT ANESTHESIOLOGY REPORTS, 2024, 14 (03) : 376 - 387
  • [24] Nutritional Management of the Critically Ill Obese Patient
    Mat-Nor, Mohd Basri
    Ibrahim, Noor Airini
    Abdullah, Fa'iza
    INTERNATIONAL MEDICAL JOURNAL MALAYSIA, 2018, 17 (02): : 143 - 148
  • [25] Human factors in the management of the critically ill patient
    Bion, J. F.
    Abrusci, T.
    Hibbert, P.
    BRITISH JOURNAL OF ANAESTHESIA, 2010, 105 (01) : 26 - 33
  • [26] THE CRITICALLY ILL OR INJURED PATIENT - PRIORITIES IN MANAGEMENT
    MAJERUS, TC
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (06): : 459 - 463
  • [27] Neuromuscular blockade management in the critically Ill patient
    J. Ross Renew
    Robert Ratzlaff
    Vivian Hernandez-Torres
    Sorin J. Brull
    Richard C. Prielipp
    Journal of Intensive Care, 8
  • [28] Management of Intermittent Hemodialysis in the Critically Ill Patient
    Chan, Ryan J.
    Helmeczi, Wryan
    Canney, Mark
    Clark, Edward G.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (02): : 245 - 255
  • [29] Drug Interaction Management in Critically Ill Patient
    Rajput, Hemraj Singh
    Shah, Nirmal, V
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (43B) : 396 - 416
  • [30] Overview of the Medical Management of the Critically Ill Patient
    Martinez, Rebecca H.
    Liu, Kathleen D.
    Aldrich, J. Matthew
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (12): : 1805 - 1813